data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Protara Therapeutics
(NASDAQ:TARA)
3.40
0.08[2.41%]
At close: Jun 24
3.35
-0.0500[-1.47%]
After Hours: 9:25AM EDT
Day High/Low3.27 - 3.6
52 Week High/Low2.72 - 10.95
Open / Close3.27 / 3.4
Float / Outstanding7.4M / 11.3M
Vol / Avg.79.6K / 32K
Mkt Cap38.3M
P/E-
50d Avg. Price3.46
Div / Yield-
Payout Ratio-
EPS-0.96
Total Float7.4M

Protara Therapeutics (NASDAQ:TARA), Quotes and News Summary

Protara Therapeutics (NASDAQ: TARA)

Day High/Low3.27 - 3.6
52 Week High/Low2.72 - 10.95
Open / Close3.27 / 3.4
Float / Outstanding7.4M / 11.3M
Vol / Avg.79.6K / 32K
Mkt Cap38.3M
P/E-
50d Avg. Price3.46
Div / Yield-
Payout Ratio-
EPS-0.96
Total Float7.4M
Benzinga - 4 days ago
Benzinga - May 12, 2022, 11:11AM
Benzinga - May 12, 2022, 8:09AM
Benzinga - May 9, 2022, 6:22AM
Benzinga - May 5, 2022, 8:10AM
Benzinga - Mar 24, 2022, 8:01AM
Benzinga - Mar 9, 2022, 7:33AM
Benzinga - Nov 8, 2021, 7:21AM
Benzinga - Nov 4, 2021, 8:33AM
Benzinga - Oct 12, 2021, 9:43AM
Benzinga - Oct 12, 2021, 8:05AM
Benzinga - Oct 12, 2021, 7:21AM
Benzinga - Oct 12, 2021, 7:01AM
Benzinga - Aug 18, 2021, 9:36AM
load more
Sector: Health Care.Industry: Biotechnology
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies to people with limited treatment options. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.900-0.960 -0.0600
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Protara Therapeutics Questions & Answers

Q
How do I buy Protara Therapeutics (TARA) stock?
A

You can purchase shares of Protara Therapeutics (NASDAQ: TARA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Protara Therapeutics's (TARA) competitors?
Q
What is the target price for Protara Therapeutics (TARA) stock?
A

The latest price target for Protara Therapeutics (NASDAQ: TARA) was reported by HC Wainwright & Co. on Monday, May 9, 2022. The analyst firm set a price target for 30.00 expecting TARA to rise to within 12 months (a possible 782.35% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Protara Therapeutics (TARA)?
A

The stock price for Protara Therapeutics (NASDAQ: TARA) is $3.4 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Protara Therapeutics (TARA) pay a dividend?
A

There are no upcoming dividends for Protara Therapeutics.

Q
When is Protara Therapeutics (NASDAQ:TARA) reporting earnings?
A

Protara Therapeutics’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Protara Therapeutics (TARA) going to split?
A

There is no upcoming split for Protara Therapeutics.

Q
What sector and industry does Protara Therapeutics (TARA) operate in?
A

Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.